- Home
- INV vs RPID Comparison
INV vs RPID Comparison
Compare INV & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INV
- RPID
- Stock Information
- Founded
- INV 2015
- RPID 2006
- Country
- INV United States
- RPID United States
- Employees
- INV N/A
- RPID N/A
- Industry
- INV
- RPID Medical Specialities
- Sector
- INV
- RPID Health Care
- Exchange
- INV NYSE
- RPID Nasdaq
- Market Cap
- INV 173.3M
- RPID 138.9M
- IPO Year
- INV N/A
- RPID 2021
- Fundamental
- Price
- INV $4.83
- RPID $3.49
- Analyst Decision
- INV Strong Buy
- RPID Buy
- Analyst Count
- INV 2
- RPID 1
- Target Price
- INV $14.00
- RPID $8.00
- AVG Volume (30 Days)
- INV 178.9K
- RPID 85.5K
- Earning Date
- INV 08-15-2025
- RPID 08-01-2025
- Dividend Yield
- INV N/A
- RPID N/A
- EPS Growth
- INV N/A
- RPID N/A
- EPS
- INV N/A
- RPID N/A
- Revenue
- INV $1,220,000.00
- RPID $29,645,000.00
- Revenue This Year
- INV $1,045.66
- RPID $18.54
- Revenue Next Year
- INV $240.46
- RPID $20.55
- P/E Ratio
- INV N/A
- RPID N/A
- Revenue Growth
- INV 18.27
- RPID 28.36
- 52 Week Low
- INV $3.00
- RPID $0.58
- 52 Week High
- INV $18.75
- RPID $4.04
- Technical
- Relative Strength Index (RSI)
- INV N/A
- RPID 57.31
- Support Level
- INV N/A
- RPID $3.06
- Resistance Level
- INV N/A
- RPID $3.49
- Average True Range (ATR)
- INV 0.00
- RPID 0.24
- MACD
- INV 0.00
- RPID -0.03
- Stochastic Oscillator
- INV 0.00
- RPID 73.42
About INV INNVENTURE INC
Innventure Inc creates, funds, operates, and rapidly scales companies in strategic collaboration with MNCs. It provides company creation, corporate strategy, technology optimization, operations, commercialization, and funding. Innventure analyzes the market, including proprietary data provided by MNCs, to identify where their well-protected, breakthrough technologies address market needs and have the potential to create $1B+ in new enterprise value.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.